Verrica Pharmaceuticals Inc.
VRCA | NASDAQ
$4.67
+$0.18 (+4.01%)
Sep 22, 2026, 12:48 PM ET · Market open
Market Data
Market Cap $77.13M
Enterprise Value $67.74M
Beta 1.50
Average Volume 64.91K
Shares Outstanding (Diluted) 21.31M
Shares Change YoY 124.49%
Institutional Ownership 22.43%
Exchange NASDAQ
ISIN US92511W2070
Price Performance
Price Change 1M -2.8%
Price Change 3M -20.5%
Price Change 6M -2.8%
Price Change YTD -45.9%
Price Change 1Y 0.7%
Price Change 3Y -88.2%
Price Change 5Y -96.1%
1M CAGR (ann.) -11.6%
1Y CAGR (ann.) 11.1%
5Y CAGR (ann.) -48.0%
All-Time CAGR -35.8%
Valuation
PE Ratio -2.04
Forward PE N/A
PEG Ratio -0.07
Forward PEG 0.07
PS Ratio 2.54
Forward PS 2.00
PB Ratio 17.91
P/FCF Ratio -3.43
P/Adj. FCF Ratio -2.87
P/OCF Ratio -7.13
EV/Sales 2.23
EV/EBIT -2.47
EV/EBITDA -2.56
EV/FCF -3.01
Earnings Yield -49.0%
FCF Yield -29.2%
Adj. FCF Yield -34.9%
Financial Health
Net Cash $9.39M
Total Debt $1.81M
Cash & Short-Term Investments $11.2M
Total Assets $36.02M
Current Ratio 1.45
Quick Ratio 1.33
Debt / Equity Ratio 0.42
Debt / EBITDA -0.07
Debt / FCF -0.08
OCF / Debt -12.44
Interest Coverage -7.54
Altman Z-Score -13.39
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 85.9%
Operating Profit Margin -92.8%
EBITDA Margin -88.6%
Net Profit Margin -102.8%
FCF Margin -74.2%
Adj. FCF Margin -88.8%
SBC / Revenue 11.6%
SBC Impact (per share) -19.6%
Returns
Return on Assets -86.6%
Return on Equity -444.4%
Return on Invested Capital -193.6%
Return on Capital Employed -207.2%
Return on Tangible Assets -86.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 52.2%
Revenue CAGR 5Y 20.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 84.9%
EPS CAGR 5Y 22.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y 48.0%
FCF CAGR 5Y -2.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 55.0%
Revenue Growth Next 3Y 43.7%
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.50
EPS Growth Est (next Q) 1558.1%
Revenue Est (next Q) $6.41M
Revenue Growth Est (next Q) -55.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $9
Price Target Upside 100.4%
Cash Flow
Operating Cash Flow $-22.51M
Free Cash Flow $-22.51M
Adj. Free Cash Flow $-26.92M
FCF Per Share -$0.63
OCF Per Share -$0.63
OCF/S Ratio -44.0%
Income Statement
Revenue $30.32M
Gross Profit $26.04M
Operating Income $-28.13M
EBITDA $-26.49M
Net Income $-31.18M
EPS (Diluted) -$2.20
Revenue / Employee $398.96K
Profit / Employee $-410.3K
Employees 76
Add to Watchlist
Select watchlists to add or remove VRCA